Velaglucerase alfa
- Generic Name
- Velaglucerase alfa
- Brand Names
- Vpriv
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 884604-91-5
- Unique Ingredient Identifier
- 23HYE36B0I
- Background
Velaglucerase alfa is a gene-activated human recombinant glucocerebrosidase used for the treatment of Type 1 Gaucher disease, caused by a deficiency of the lysosomal enzyme glucocerebrosidase. Additionally, Velaglucerase alfa has also been investigated for use in Type 3 Gaucher disease.
- Indication
Velaglucerase alfa is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for long-term enzyme replacement therapy for pediatric and adult patients with type 1 Gaucher disease.
- Associated Conditions
- Gaucher Disease, Type 1
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath